The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Honoraria - Amoy Diagnostics; CStone Pharmaceuticals; Hengrui Pharmaceutical; Innovent Biologics; Lilly China; Luye Pharma; Luye Pharma; MSD; QiLu Pharmaceutical; Roche; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Hengrui Pharmaceutical; Innovent Biologics; Qilu Puget Sound Biotherapeutics; TopAlliance BioSciences Inc

The effects of tislelizumab treatment on the health-related quality of life of non-small cell lung cancer patients who progressed on a prior platinum-containing regimen.
 
Cai Zhou
No Relationships to Disclose
 
Dingzhi Huang
Consulting or Advisory Role - BeiGene
Research Funding - BeiGene
 
Yiyuan Ma
No Relationships to Disclose
 
Zhenyu Pan
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Gisoo Barnes
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Boxiong Tang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene